These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 25046655)

  • 41. Expansion of CD26 positive fibroblast population promotes keloid progression.
    Xin Y; Wang X; Zhu M; Qu M; Bogari M; Lin L; Mar Aung Z; Chen W; Chen X; Chai G; Zhang Y
    Exp Cell Res; 2017 Jul; 356(1):104-113. PubMed ID: 28454879
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative study of microRNA profiling in keloid fibroblast and annotation of differential expressed microRNAs.
    Li C; Bai Y; Liu H; Zuo X; Yao H; Xu Y; Cao M
    Acta Biochim Biophys Sin (Shanghai); 2013 Aug; 45(8):692-9. PubMed ID: 23709205
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Compound Astragalus and Salvia miltiorrhiza extract inhibits cell proliferation, invasion and collagen synthesis in keloid fibroblasts by mediating transforming growth factor-β / Smad pathway.
    He S; Yang Y; Liu X; Huang W; Zhang X; Yang S; Zhang X
    Br J Dermatol; 2012 Mar; 166(3):564-74. PubMed ID: 21967214
    [TBL] [Abstract][Full Text] [Related]  

  • 44. TGF-beta1 increases cell rigidity by enhancing expression of smooth muscle actin: keloid-derived fibroblasts as a model for cellular mechanics.
    Lee CH; Hong CH; Chen YT; Chen YC; Shen MR
    J Dermatol Sci; 2012 Sep; 67(3):173-80. PubMed ID: 22771320
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased c-Met phosphorylation is related to keloid pathogenesis: implications for the biological behaviour of keloid fibroblasts.
    Jin Z
    Pathology; 2014 Jan; 46(1):25-31. PubMed ID: 24300717
    [TBL] [Abstract][Full Text] [Related]  

  • 46. miR-196a downregulation increases the expression of type I and III collagens in keloid fibroblasts.
    Kashiyama K; Mitsutake N; Matsuse M; Ogi T; Saenko VA; Ujifuku K; Utani A; Hirano A; Yamashita S
    J Invest Dermatol; 2012 Jun; 132(6):1597-604. PubMed ID: 22358059
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Promoted activation of matrix metalloproteinase (MMP)-2 in keloid fibroblasts and increased expression of MMP-2 in collagen bundle regions: implications for mechanisms of keloid progression.
    Imaizumi R; Akasaka Y; Inomata N; Okada E; Ito K; Ishikawa Y; Maruyama Y
    Histopathology; 2009 May; 54(6):722-30. PubMed ID: 19438747
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dexamethasone induction of keloid regression through effective suppression of VEGF expression and keloid fibroblast proliferation.
    Wu WS; Wang FS; Yang KD; Huang CC; Kuo YR
    J Invest Dermatol; 2006 Jun; 126(6):1264-71. PubMed ID: 16575391
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of heat shock protein 47 on collagen synthesis of keloid in vivo.
    Chen JJ; Jin PS; Zhao S; Cen Y; Liu Y; Xu XW; Duan WQ; Wang HS
    ANZ J Surg; 2011 Jun; 81(6):425-30. PubMed ID: 22295344
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transdermal delivery of 10,11-methylenedioxycamptothecin by hyaluronic acid based nanoemulsion for inhibition of keloid fibroblast.
    Gao Y; Cheng X; Wang Z; Wang J; Gao T; Li P; Kong M; Chen X
    Carbohydr Polym; 2014 Nov; 112():376-86. PubMed ID: 25129757
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PAX5 activates telomerase activity and proliferation in keloid fibroblasts by transcriptional regulation of SND1, thus promoting keloid growth in burn-injured skin.
    Qin G; Sun Y; Guo Y; Song Y
    Inflamm Res; 2021 Apr; 70(4):459-472. PubMed ID: 33616676
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interactions of primary fibroblasts and keratinocytes with extracellular matrix proteins: contribution of alpha2beta1 integrin.
    Zhang ZG; Bothe I; Hirche F; Zweers M; Gullberg D; Pfitzer G; Krieg T; Eckes B; Aumailley M
    J Cell Sci; 2006 May; 119(Pt 9):1886-95. PubMed ID: 16636073
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acidic and basic fibroblast growth factors down-regulate collagen gene expression in keloid fibroblasts.
    Tan EM; Rouda S; Greenbaum SS; Moore JH; Fox JW; Sollberg S
    Am J Pathol; 1993 Feb; 142(2):463-70. PubMed ID: 7679551
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of selenocystine on gene expression profiles in human keloid fibroblasts.
    De Felice B; Garbi C; Wilson RR; Santoriello M; Nacca M
    Genomics; 2011 May; 97(5):265-76. PubMed ID: 21371550
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars.
    Bock O; Yu H; Zitron S; Bayat A; Ferguson MW; Mrowietz U
    Acta Derm Venereol; 2005; 85(3):216-20. PubMed ID: 16040405
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Single-cell RNA-seq reveals fibroblast heterogeneity and increased mesenchymal fibroblasts in human fibrotic skin diseases.
    Deng CC; Hu YF; Zhu DH; Cheng Q; Gu JJ; Feng QL; Zhang LX; Xu YP; Wang D; Rong Z; Yang B
    Nat Commun; 2021 Jun; 12(1):3709. PubMed ID: 34140509
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Asiaticoside suppresses collagen expression and TGF-β/Smad signaling through inducing Smad7 and inhibiting TGF-βRI and TGF-βRII in keloid fibroblasts.
    Tang B; Zhu B; Liang Y; Bi L; Hu Z; Chen B; Zhang K; Zhu J
    Arch Dermatol Res; 2011 Oct; 303(8):563-72. PubMed ID: 21240513
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Syndecan-2 and decorin: proteoglycans with a difference--implications in keloid pathogenesis.
    Mukhopadhyay A; Wong MY; Chan SY; Do DV; Khoo A; Ong CT; Cheong HH; Lim IJ; Phan TT
    J Trauma; 2010 Apr; 68(4):999-1008. PubMed ID: 20386290
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metabolic reprogramming in keloid fibroblasts: Aerobic glycolysis and a novel therapeutic strategy.
    Li Q; Qin Z; Nie F; Bi H; Zhao R; Pan B; Ma J; Xie X
    Biochem Biophys Res Commun; 2018 Feb; 496(2):641-647. PubMed ID: 29337061
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of vascular endothelial growth factor expression in keloid fibroblasts by vector-mediated vascular endothelial growth factor shRNA: a therapeutic potential strategy for keloid.
    Zhang GY; Yi CG; Li X; Zheng Y; Niu ZG; Xia W; Meng Z; Meng CY; Guo SZ
    Arch Dermatol Res; 2008 Apr; 300(4):177-84. PubMed ID: 18239926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.